JB Tougouma, F Boccara, C Meuleman… - Archives of …, 2011 - Elsevier ... Infectieuses, Paris, France Objective: Human immunodeficiency virus (HIV)-infected patients receiving combined active antiretroviral therapy (cART) are at higher risk of cardiovascular disease, due in part to metabolic complications such as lipod- ystrophy syndrome, insulin ...
F Boccara, E Catez, C Meuleman, S Ederhy… - Archives of …, 2011 - Elsevier ... Infectieuses, Paris, France Objective: Human immunodeficiency virus (HIV)-infected patients receiving combined active antiretroviral therapy (cART) are at higher risk of cardiovascular disease, due in part to metabolic complications such as lipod- ystrophy syndrome, insulin ...
E Bruckert, G Bonnelye, F Thomas… - Archives of …, 2011 - Elsevier ... Infectieuses, Paris, France Objective: Human immunodeficiency virus (HIV)-infected patients receiving combined active antiretroviral therapy (cART) are at higher risk of cardiovascular disease, due in part to metabolic complications such as lipod- ystrophy syndrome, insulin ...
DC Grinnan… - A Practical Guide to Mechanical …, 2011 - Wiley Online Library ... tracheotomy. However, patients with both bulbar signs and significant respiratory muscle weakness (as manifest by hypercapnia) may have improved quality of life with NIV. 1.7.3.2 Duchenne ' sm uscular d ystrophy ( DMD ) Duchenne ... Related articles
B Wustman - US Patent App. 12/986,506, 2011 - Google Patents Page 1. US 20110105560A1 (i9) United States (12) Patent Application Publication oo) Pub. No.: US 2011/0105560 Al Wustman (43) Pub. Date: May 5,2011 (54) TREATMENT OF CNS DISORDERS ASSOCIATED WITH MUTATIONS ... All 2 versions